News
MicroStrategy has issued over $3 billion of preferred stock with rates as high as 11.5%, a tactic that has generated ...
Enliven Therapeutics, Inc. (NASDAQ: ELVN) has announced the pricing of its underwritten public offering of 8,394,737 shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback